Standard Biotools (LAB) Common Equity (2010 - 2026)
Standard Biotools (LAB) posted quarterly Common Equity of $561.1 million for Q1 2026, up 23.43% year-over-year from $454.6 million in Q1 2025, and up 32.25% quarter-over-quarter from $424.3 million in Q4 2025.
Standard Biotools (LAB) Common Equity (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Common Equity for 17 consecutive years, with $561.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 23.43% year-over-year to $561.1 million; the TTM figure through Mar 2026 stood at $561.1 million (up 23.43% YoY), while the FY2025 annual figure was $424.3 million, down 10.05% from the prior year.
- Common Equity climbed to $561.1 million in Q1 2026 per LAB's latest filing, from $424.3 million in the prior quarter.
- Across five years, Common Equity topped out at $577.3 million in Q1 2024 and bottomed at -$148.1 million in Q4 2023.
- Historically, Common Equity has averaged $215.5 million across 5 years, with a median of $399.7 million in 2025.
- Annual changes were most pronounced in 2023 — Common Equity sank 539.35% — and 2024, when it soared 694.23%.
- Standard Biotools' Common Equity stood at -$81.5 million in 2022, then sank by 81.73% to -$148.1 million in 2023, then soared by 418.62% to $471.7 million in 2024, then declined by 10.05% to $424.3 million in 2025, then surged by 32.25% to $561.1 million in 2026.
- Business Quant data shows LAB's Common Equity at $561.1 million in Q1 2026, $424.3 million in Q4 2025, and $399.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 127.31 Bn | 123.83 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.93 Bn | 109.71 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.82 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn | 539.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 539.97 Mn |
| Mar 31, 2026 | 561.12 Mn |
| Dec 31, 2025 | 424.29 Mn |
| Sep 30, 2025 | 399.66 Mn |
| Jun 30, 2025 | 424.54 Mn |
| Mar 31, 2025 | 454.60 Mn |
| Dec 31, 2024 | 471.72 Mn |
| Sep 30, 2024 | 489.33 Mn |
| Jun 30, 2024 | 510.26 Mn |
| Mar 31, 2024 | 577.32 Mn |
| Dec 31, 2023 | -148.05 Mn |
| Sep 30, 2023 | -131.72 Mn |
| Jun 30, 2023 | -113.39 Mn |
| Mar 31, 2023 | -97.15 Mn |
| Dec 31, 2022 | -81.47 Mn |
| Sep 30, 2022 | -62.75 Mn |
| Jun 30, 2022 | -37.45 Mn |
| Mar 31, 2022 | 22.11 Mn |
| Dec 31, 2021 | 94.60 Mn |
| Sep 30, 2021 | 99.34 Mn |